Windtree Therapeutics to Invest $700 Million in BNB, Following Corporate Crypto Trend

preview image

Nasdaq-listed biopharmaceutical company Windtree Therapeutics has announced its intention to acquire up to $700 million worth of BNB, the native cryptocurrency of the BNB Chain. This significant investment follows a recent all-time high for BNB and aligns with a growing trend of publicly traded companies diversifying their treasuries with digital assets.

Read more

Comments

Popular posts from this blog

BitMEX Exposes Lazarus Group's Cyber Security Vulnerabilities

Crypto Markets Under Pressure: Fear Hits 10, ETF Outflows Mount, and Policy Battles Intensify

Bitcoin Holds Near $65K as ETF Inflows Return, Miner Stress Eases